Ablazione con radiofrequenza del fegato in Israele — ricevi 3 opzioni di cliniche personalizzate

Il Prof. Merimsky è un esperto di fama nel campo dell'ablazione dei tumori epatici, con decenni di esperienza specializzata presso il Sourasky Medical Center.

• Oltre 25 anni di pratica oncologica mirata
• Specializzato nel trattamento dei sarcomi e dei tumori ossei
• Fellowship presso l'Institut Gustave Roussy di Parigi
• Membro delle società professionali ESMO e ASCO
• Ha pubblicato ampiamente su terapie oncologiche innovative

La Dott.ssa Pelles Sharon è specializzata nei trattamenti per il cancro al fegato, inclusa l'ablazione con radiofrequenza, presso il Sourasky Medical Center.

• Ampia esperienza in vari trattamenti oncologici
• Ha condotto ricerche cliniche sugli atteggiamenti dei pazienti oncologici
• Offre una gamma di opzioni chirurgiche e non chirurgiche
• Parte di un rispettato team oncologico

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.